The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

Stephen M. Stick, Alexia Foti, Robert S. Ware, Harm A.W.M. Tiddens, Barry Clements, David Armstrong, Hiran Selvadurai, Andrew Tai, Peter Cooper, Catherine A. Byrnes, Yvonne Belessis, Claire Wainwright, Adam Jaffé, Philip Robinson, Lisa Saiman, Peter D. Sly